BDNF and depressive disorder: MYR administration significantly reversed the SPS-induced reduction of BDNF mRNA expression, which suggests that its beneficial effects on depression- and anxiety-like behaviors were mediated by an increase in BDNF expression that may be associated with enhanced neuronal function.